Search research articles
Contact Us
Filters
Showing results (41-50 of 159) with videos related to
Page
of 16
Sort By:
Open Forum Infectious Diseases
|
April 17, 2023
The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal <i>ampC</i> Expression
Dariusz Hareza, Patricia J Simner, Yehudit Bergman, et al.
Journal of Clinical Microbiology
|
June 17, 2025
Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleading
Joseph L Kuti, Joseph D Lutgring, Patricia J Simner, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
October 7, 2021
Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales
Patricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Antimicrobial Agents and Chemotherapy
|
August 19, 2024
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilli
Lili Tao, Ashley Dahlquist, Harley Harris, et al.
Open Forum Infectious Diseases
|
July 7, 2023
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance
Patricia J Simner, Yehudit Bergman, Rick Conzemius, et al.
Journal of Clinical Microbiology
|
March 8, 2019
A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among <i>Enterobacteriales</i>
Drew T Bell, Yehudit Bergman, Abida Q Kazmi, et al.
Open Forum Infectious Diseases
|
July 15, 2021
Cefiderocol Activity Against Clinical <i>Pseudomonas aeruginosa</i> Isolates Exhibiting Ceftolozane-Tazobactam Resistance
Patricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Antimicrobial Agents and Chemotherapy
|
June 22, 2023
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program
Michael J Satlin, Patricia J Simner, Christine M Slover, et al.
Journal of Clinical Microbiology
|
September 17, 2020
Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth Microdilution
C Paul Morris, Yehudit Bergman, Tsigedera Tekle, et al.
Journal of Clinical Microbiology
|
April 8, 2016
Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs
Patricia J Simner, Isabella Martin, Belita Opene, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 159) with videos related to
Sort By:
Page
of 16
Open Forum Infectious Diseases
|
April 17, 2023
The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal <i>ampC</i> Expression
Dariusz Hareza, Patricia J Simner, Yehudit Bergman, et al.
Journal of Clinical Microbiology
|
June 17, 2025
Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleading
Joseph L Kuti, Joseph D Lutgring, Patricia J Simner, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
October 7, 2021
Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales
Patricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Antimicrobial Agents and Chemotherapy
|
August 19, 2024
Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilli
Lili Tao, Ashley Dahlquist, Harley Harris, et al.
Open Forum Infectious Diseases
|
July 7, 2023
An NDM-Producing <i>Escherichia coli</i> Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance
Patricia J Simner, Yehudit Bergman, Rick Conzemius, et al.
Journal of Clinical Microbiology
|
March 8, 2019
A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among <i>Enterobacteriales</i>
Drew T Bell, Yehudit Bergman, Abida Q Kazmi, et al.
Open Forum Infectious Diseases
|
July 15, 2021
Cefiderocol Activity Against Clinical <i>Pseudomonas aeruginosa</i> Isolates Exhibiting Ceftolozane-Tazobactam Resistance
Patricia J Simner, Stephan Beisken, Yehudit Bergman, et al.
Antimicrobial Agents and Chemotherapy
|
June 22, 2023
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program
Michael J Satlin, Patricia J Simner, Christine M Slover, et al.
Journal of Clinical Microbiology
|
September 17, 2020
Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-Negative Bacilli: a Comparison of Disk Diffusion to Broth Microdilution
C Paul Morris, Yehudit Bergman, Tsigedera Tekle, et al.
Journal of Clinical Microbiology
|
April 8, 2016
Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs
Patricia J Simner, Isabella Martin, Belita Opene, et al.
Page
of 16